Cann Group Limited

ASX:CAN.AX

0.04 (AUD) • At close September 16, 2024
Bedrijfsnaam Cann Group Limited
Symbool CAN.AX
Munteenheid AUD
Prijs 0.038
Beurswaarde 17,819,606
Dividendpercentage 0%
52-weken bereik 0.027 - 0.19
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Peter Koetsier
Website https://www.canngrouplimited.com

An error occurred while fetching data.

Over Cann Group Limited

Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is

Vergelijkbare Aandelen

Prescient Therapeutics Limited logo

Prescient Therapeutics Limited

PTX.AX

0.041 AUD

Kazia Therapeutics Limited logo

Kazia Therapeutics Limited

KZA.AX

0.08 AUD

SomnoMed Limited logo

SomnoMed Limited

SOM.AX

0.44 AUD

Proteomics International Laboratories Limited logo

Proteomics International Laboratories Limited

PIQ.AX

0.6 AUD

Vita Life Sciences Limited logo

Vita Life Sciences Limited

VLS.AX

2.15 AUD

Cyclopharm Limited logo

Cyclopharm Limited

CYC.AX

1.445 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)